Abstract
Primary biliary cholangitis is a rare progressive chronic inflammation of the medium and small bile ducts that abdominal radiologists may encounter, particularly if working in a tertiary setting or at a transplant center. This brief review covers current thinking about the pathophysiology and presentation of the disease, as well as the current diagnostic criteria in use by hepatologists. Imaging strategies for diagnosis will be reviewed as well as current treatment strategies and the use of imaging in monitoring response to treatment, including image-guided elastography.
Graphical abstract
Similar content being viewed by others
References
Beuers U, Boberg KM, Chapman RW, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-67.
Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ’cirrhosis’ to ’cholangitis’. Hepatology 2015;62(5):1620–2.
Lleo A, Colapietro F. Changes in the Epidemiology of Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):429-41.
Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest. 2002;109(9):1231-40.
Carrion AF, Rosen JD, Levy C. Understanding and Treating Pruritus in Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):517-32.
Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50(1):291-308.
Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int 2015;35:636–641.
Hirschfield GM, Beuers U, Corpechot C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145-72.
Tan D, Goodman ZD. Liver Biopsy in Primary Biliary Cholangitis: Indications and Interpretation. Clin Liver Dis. 2018;22(3):579-88.
Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379(2):103-12.
Tanaka A, Leung PSC, Gershwin ME. The Genetics and Epigenetics of Primary Biliary Cholangitis. Clin Liver Dis. 2018;22(3):443-55.
Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology. 1990;11(5):730-4.
Chalifoux SL, Konyn PG, Choi G, Saab S. Extrahepatic Manifestations of Primary Biliary Cholangitis. Gut Liver. 2017;11(6):771-80.
Glass LM, Su GL. Metabolic Bone Disease in Primary Biliary Cirrhosis. Gastroenterol Clin North Am. 2016;45(2):333-43.
Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69(1):394-419.
Kobayashi S, Matsui O, Gabata T, et al. MRI findings of primary biliary cirrhosis: correlation with Scheuer histologic staging. Abdom Imaging. 2005;30(1):71-6.
Haliloglu N, Erden A, Erden I. Primary biliary cirrhosis: evaluation with T2-weighted MR imaging and MR cholangiopancreatography. Eur J Radiol. 2009;69(3):523-7.
Kovač JD, Ješić R, Stanisavljević D, et al. Integrative role of MRI in the evaluation of primary biliary cirrhosis. Eur Radiol. 2012;22(3):688-94.
Idilman IS, Venkatesh SH, Eaton JE, et al. Magnetic resonance imaging features in 283 patients with primary biliary cholangitis. Eur Radiol. 2020;30(9):5139-48.
Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford). 2010;12(8):567-76.
Han D, Liu J, Jin E, He W. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Jpn J Radiol. 2019;37(5):412-9.
Takeyama Y, Tsuchiya N, Kunimoto H, et al. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis. Hepatol Res. 2015;45(10):E108-14.
Wenzel JS, Donohoe A, Ford KL, Glastad K, Watkins D, Molmenti E. Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. AJR Am J Roentgenol. 2001;176(4):885-9.
Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY). 2017;42(2):490-501.
Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273
Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220:329–336
Corpechot C, Carrat F, Poujol-Robert A, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012;56(1):198-208.
Zhang DK, Chen M, Liu Y, Wang RF, Liu LP, Li M. Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: A preliminary study. Clin Radiol. 2014;69(8):836-40.
Goertz RS, GaBmann L, Strobel D, et al. Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases. Ann Hepatol. 2019;18(1):23-9.
Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology. 2020;296(2):263-74.
Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls. Radiographics. 2019;39(7):1983-2002.
Osman KT, Maselli DB, Idilman IS, et al. Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis. J Clin Gastroenterol. 2021;55(5):449-57.
Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2015;40(4):818-34.
Kowdley KV. An Examination of the Evidence Behind Biochemical Markers in Primary Biliary Cholangitis. Gastroenterol Hepatol (N Y). 2021;17(5 Suppl 5):5-11.
Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28(2):296-301.
Hyslop WB, Kierans AS, Leonardou P, et al. Overlap syndrome of autoimmune chronic liver diseases: MRI findings. J Magn Reson Imaging. 2010;31(2):383-9.
Ringe KI, Bergquist A, Lenzen H, et al. Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC). Eur J Radiol. 2020;129:109101.
Katabathina VS, Khalil S, Shin S, Lath N, Menias CO, Prasad SR. Immunoglobulin G4-Related Disease: Recent Advances in Pathogenesis and Imaging Findings. Radiol Clin North Am. 2016;54(3):535-51.
Guidry C, Fricke RG, Ram R, Pandey T, Jambhekar K. Imaging of Sarcoidosis: A Contemporary Review. Radiol Clin North Am. 2016;54(3):519-34.
Poupon R. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action. Clin Res Hepatol Gastroenterol 2012;36(Suppl 1):S3–12.
Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106(5):1284–90.
Poupon RE, Lindor KD, Pares A, et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003;39(1):12–6.
FDA Drug Safety Communication, 05–26–2021 [Accessed October 16, 2021] Available at: https://www.fda.gov/media/149516/download
Corpechot C, Chazouillères O, Rousseau A, et al. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N Engl J Med. 2018;378(23):2171-81.
Locke GR 3rd, Therneau TM, Ludwig J, et al. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996;23(1):52–6.
Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20(6):707–13.
Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol. 2011;35(6-7):446-54.
Assis DN. Chronic Complications of Cholestasis: Evaluation and Management. Clin Liver Dis. 2018;22(3):533-44.
Funding
No funding or research support for this article.
Author information
Authors and Affiliations
Contributions
Both authors made substantial contributions to the conception or design of the work; drafted the work or revised it critically for important intellectual content; approved the version to be published; and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest or competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morgan, M.A., Sundaram, K.M. Primary biliary cholangitis: review for radiologists. Abdom Radiol 48, 127–135 (2023). https://doi.org/10.1007/s00261-021-03335-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-021-03335-x